Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 1
1976 1
1979 4
1980 1
1981 2
1982 1
1983 2
1984 4
1985 3
1986 2
1987 3
1988 3
1989 10
1990 5
1991 4
1992 2
1993 7
1994 4
1995 7
1996 8
1997 9
1998 6
1999 16
2000 8
2001 12
2002 13
2003 8
2004 6
2005 7
2006 11
2007 10
2008 8
2009 7
2010 5
2011 5
2012 8
2013 7
2014 8
2015 6
2016 10
2017 4
2018 1
2019 7
2020 6
2021 4
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma.
Mattiucci GC, Autorino R, D'Agostino GR, Deodato F, Macchia G, Perri V, Tringali A, Morganti AG, Mutignani M, Valentini V. Mattiucci GC, et al. Crit Rev Oncol Hematol. 2014 Apr;90(1):58-67. doi: 10.1016/j.critrevonc.2013.10.007. Epub 2013 Nov 2. Crit Rev Oncol Hematol. 2014. PMID: 24289902 Review.
BACKGROUND: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when radiotherapy could be effective for this group of patients. ...
BACKGROUND: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when …
Prognostic Factors for Distal Bile Duct Carcinoma After Surgery.
Kawahara R, Midorikawa R, Taniwaki S, Kojima S, Kanno H, Yoshitomi M, Nomura Y, Goto Y, Satou T, Sakai H, Ishikawa H, Hisaka T, Yasunaga M, Sakaue T, Ushijima T, Yasumoto M, Okabe Y, Tanigawa M, Naitou Y, Yano H, Okuda K. Kawahara R, et al. Kurume Med J. 2023 Jul 3;68(2):81-89. doi: 10.2739/kurumemedj.MS682002. Epub 2023 Mar 31. Kurume Med J. 2023. PMID: 37005293 Free article.
BACKGROUND: Distal bile duct carcinoma continues to be one of the most difficult cancers to manage in terms of staging and radical resection. Pancreaticoduodenectomy (PD) with regional lymph node dissection has become the standard treatment of distal bile
BACKGROUND: Distal bile duct carcinoma continues to be one of the most difficult cancers to manage in terms of staging …
Liver tumours.
Anthony PP. Anthony PP. Baillieres Clin Gastroenterol. 1988 Apr;2(2):501-22. doi: 10.1016/0950-3528(88)90014-0. Baillieres Clin Gastroenterol. 1988. PMID: 2841989 Review.
Thorium dioxide will remain a risk factor for the development of angiosarcoma, liver cell carcinoma and bile duct carcinoma for some time yet, and the number of patients who have been exposed is high--tens of thousands at least. ...
Thorium dioxide will remain a risk factor for the development of angiosarcoma, liver cell carcinoma and bile duct carcinoma
Malignant jaundice.
Huang JF, Little JM. Huang JF, et al. Aust N Z J Surg. 1987 Dec;57(12):905-9. doi: 10.1111/j.1445-2197.1987.tb01292.x. Aust N Z J Surg. 1987. PMID: 2449885
Fifty-five consecutive patients presenting to a Surgical Unit for management of malignant obstructive jaundice are reported in this paper. An increasing incidence of bile-duct carcinoma has been noted since the end of 1983. The hospital mortality for all case …
Fifty-five consecutive patients presenting to a Surgical Unit for management of malignant obstructive jaundice are reported in this paper. A …
Treatment of mid-bile duct carcinoma: Local resection or pancreatoduodenectomy?
Schreuder AM, Engelsman AF, van Roessel S, Verheij J, Besselink MG, van Gulik TM, Busch OR. Schreuder AM, et al. Eur J Surg Oncol. 2019 Nov;45(11):2180-2187. doi: 10.1016/j.ejso.2019.06.032. Epub 2019 Jun 29. Eur J Surg Oncol. 2019. PMID: 31279596
INTRODUCTION: Whereas distal cholangiocarcinoma (DC) is treated by pancreatoduodenectomy (PD), consensus is lacking on treatment of mid-bile duct carcinoma (mid-BDC) without involvement of the pancreatic head. ...
INTRODUCTION: Whereas distal cholangiocarcinoma (DC) is treated by pancreatoduodenectomy (PD), consensus is lacking on treatment of mid-b
Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: report of six cases and review of the literature.
Mir-Madjlessi SH, Farmer RG, Sivak MV Jr. Mir-Madjlessi SH, et al. Dig Dis Sci. 1987 Feb;32(2):145-54. doi: 10.1007/BF01297102. Dig Dis Sci. 1987. PMID: 3542446 Review.
The relative risk of bile duct carcinoma in patients with ulcerative colitis was 31.3. ...Both sclerosing cholangitis and bile duct carcinoma are rare in Crohn's disease....
The relative risk of bile duct carcinoma in patients with ulcerative colitis was 31.3. ...Both sclerosing cholangitis a …
Intraductal papillary neoplasm of the bile duct.
Wan XS, Xu YY, Qian JY, Yang XB, Wang AQ, He L, Zhao HT, Sang XT. Wan XS, et al. World J Gastroenterol. 2013 Dec 14;19(46):8595-604. doi: 10.3748/wjg.v19.i46.8595. World J Gastroenterol. 2013. PMID: 24379576 Free PMC article. Review.
Intraductal papillary neoplasm of the bile duct (IPNB) is a variant of bile duct carcinoma that is characterized by intraductal growth and better outcomes compared with common cholangiocarcinoma. ...
Intraductal papillary neoplasm of the bile duct (IPNB) is a variant of bile duct carcinoma that is characterized by int …
Invasive micropapillary carcinoma of the extrahepatic bile duct and its malignant potential.
Yoshizawa T, Toyoki Y, Hirai H, Haga T, Toba T, Sakuraba S, Okano K, Wu Y, Seino H, Morohashi S, Hakamada K, Kijima H. Yoshizawa T, et al. Oncol Rep. 2014 Oct;32(4):1355-61. doi: 10.3892/or.2014.3394. Epub 2014 Aug 7. Oncol Rep. 2014. PMID: 25109922 Free PMC article.
Presence of IMPC component was significantly associated with poor overall survival (P=0.003). In conclusion, extrahepatic bile duct carcinoma with IMPC component showed significant lymphatic invasion, lymph node metastasis, and resulted in poor prognosis....
Presence of IMPC component was significantly associated with poor overall survival (P=0.003). In conclusion, extrahepatic bile duc
Status of surgical treatment of biliary tract cancer.
Ishihara S, Miyakawa S, Takada T, Takasaki K, Nimura Y, Tanaka M, Miyazaki M, Nagakawa T, Kayahara M, Horiguchi A. Ishihara S, et al. Dig Surg. 2007;24(2):131-6. doi: 10.1159/000101901. Epub 2007 Apr 19. Dig Surg. 2007. PMID: 17446708 Free article. Review.
We report here the status of biliary surgery in Japan. For hilar bile duct carcinoma, major hepatectomy is needed to increase the resection rate, and total caudate lobectomy is required for curative resection. ...
We report here the status of biliary surgery in Japan. For hilar bile duct carcinoma, major hepatectomy is needed to in …
255 results